Dr. Lal Path Labs Ltd. has informed the Exchange about Schedule of meet
LALPATHLAB · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Dr. Lal PathLabs has scheduled an earnings conference call for investors and analysts on Friday, January 30, 2026, at 4:00 PM IST to discuss its Q3 and 9M FY26 financial and operating performance. The company's Q3 and 9M FY26 results will be announced on the same day before the call. The management will be represented by Executive Chairman Dr. Arvind Lal, CEO Shankha Banerjee, and Group CFO & CEO (International Business) Ved Prakash Goel. Participants can pre-register through a link or dial in via Indian or international toll numbers. The intimation is filed with both NSE and BSE under SEBI's Listing Obligations and Disclosure Requirements Regulations 2015.
This is a routine procedural disclosure with no direct impact on the stock price. Investors should track the Q3 FY26 results announcement on January 30, 2026, as the actual numbers and management commentary during the call could influence the stock based on performance versus market expectations.